Verily, Sosei Heptares Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated Diseases

new research collaboration combining Verily’s Immune Profiler platform, a next gen immune mapping platform, with Sosei Heptares’ world-leading StaR (stabilized receptor) platform,

Related Keywords

Sosei Heptares , ,Sosei Heptares Collaborate ,Generate Novel Drug Candidates Against ,Should Know ,Immune Profiler ,